Regulation of the activity of sodium, potassium-ATPase (NKA, the sodium pump) is a critical element in the maintenance of extracellular fluid volume and blood pressure. When the enzyme is resident in its functional location in the cell membrane, regulation of the enzyme is possible at both the intracellular and extracellular surfaces. At the intracellular surface the enzyme is regulated by signals arising from cell surface receptors for humoral substances such as angiotensin II, dopamine and norepinephrine. There is now evidence that these signals alter the vectorial transport produced by NKA by changing its subcellular distribution (endosomal sequestration). At its extracellular surface, NKA projects a highly conserved cardiotonic steroid binding site which is an integral part of the enzyme and which serves no other function except to bind cardiotonic steroids with high affinity. Recent work in our laboratory and work by others in the field has defined the chemical identity of substances which bind to and inhibit the enzyme through the cardiotonic steroid receptor. We have shown that this inhibitor is an endogenous substance synthesized by the adrenal cortex. The present studies will further refine our understanding of the function of adrenocortical cardiotonic steroid. The present studies will further refine our understanding of the function of adrenocortical cardiotonic steroid. We will delineate important features of the biosynthetic pathway which leads to formation of the endogenous adrenal cardiotonic steroid. We will examine the role of cholesterol and cholesterol side chain cleavage in the metabolic pathway leading to the production of adrenal cardiotonic steroid. We will examine the control of activity in this novel steroidogenic surface receptors. Finally, we will examine and characterize the interaction between adrenal cardiotonic steroid and its receptor binding site on renal sodium, potassium-ATPase. We will also determine if the interaction with this site coordinates with regulation of ATPase activity by humoral substances and whether the mechanism of coordination occurs through increased sequestration of the receptor protein.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045538-10
Application #
6517246
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Tondravi, Mehrdad M
Project Start
1997-04-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2004-06-30
Support Year
10
Fiscal Year
2002
Total Cost
$198,013
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Genetics
Type
Schools of Public Health
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Dmitrieva, Renata I; Hinojos, Cruz A; Grove, Megan L et al. (2009) Genome-wide identification of allelic expression in hypertensive rats. Circ Cardiovasc Genet 2:106-15
Dmitrieva, Renata I; Hinojos, Cruz A; Boerwinkle, Eric et al. (2008) Hepatocyte nuclear factor 1 and hypertensive nephropathy. Hypertension 51:1583-9
Dmitrieva, Renata I; Lalli, Enzo; Doris, Peter A (2005) Regulation of adrenocortical cardiotonic steroid production by dopamine and PKA signaling. Front Biosci 10:2489-95
Doris, Peter A; Fornage, Myriam (2005) The transcribed genome and the heritable basis of essential hypertension. Cardiovasc Toxicol 5:95-108
Hinojos, Cruz A; Boerwinkle, Eric; Fornage, Myriam et al. (2005) Combined genealogical, mapping, and expression approaches to identify spontaneously hypertensive rat hypertension candidate genes. Hypertension 45:698-704
Hinojos, Cruz A; Doris, Peter A (2004) Altered subcellular distribution of Na+,K+-ATPase in proximal tubules in young spontaneously hypertensive rats. Hypertension 44:95-100
Abramowitz, Joel; Dai, Cuiping; Hirschi, Karen K et al. (2003) Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5. Circulation 108:3048-53
Dmitrieva, Renata I; Doris, Peter A (2003) Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells. J Biol Chem 278:28160-6
Fornage, Myriam; Hinojos, Cruz A; Nurowska, Barbara W et al. (2002) Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats. Hypertension 40:485-90
Doris, Peter A (2002) Hypertension genetics, single nucleotide polymorphisms, and the common disease:common variant hypothesis. Hypertension 39:323-31

Showing the most recent 10 out of 33 publications